Portfolio company
Anthology Biotechnologies
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops engineered microbes and designer genomes for biopharmaceutical and industrial biotechnology firms to enable cost-efficient protein and chemical production.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Anthrogen
This company develops artificial intelligence models and experimental infrastructure to design modular proteins and biological machines for healthcare, industrial and climate applications.
Ansa Biotechnologies
This company manufactures synthetic DNA using enzymatic synthesis technology for researchers in biological engineering, therapeutics, diagnostics and agriculture.
Think Bioscience
This company develops small-molecule therapeutics for pharmaceutical researchers by using synthetic biology and engineered microbes to target difficult-to-drug proteins.
Silicozyme
This company develops enzymatic toolkits and bioprocessing technologies for protein manufacturing and biologics production for industrial biotechnology and pharmaceutical customers.
General Biotechnologies
This company develops genetically programmed edible microbes to manufacture oral peptide therapeutics for patients with metabolic diseases and other chronic conditions.
Aether
Aether Bio uses artificial intelligence and robotic laboratories to engineer enzymes for customers in the pharmaceutical and chemical manufacturing sectors.
Wild Microbes
The company develops engineered microbial hosts for biomanufacturing industries to produce ingredients and chemicals via precision fermentation.
Bitrobius Genetics
This company develops synthetic gene transfer technology for researchers and pharmaceutical firms to manufacture and deliver cell and gene therapies and vaccines.
